We’re harnessing our deep knowledge of inflammatory mechanisms and the science of the immune system to redefine the future of respiratory medicine and target lung, liver and kidney disease.
Our ambition is to help increase overall quality of life, maximise survival, and change the course of disease, expanding from our current focus on blood and women’s cancers into lung and gastrointestinal cancers, as well as other solid tumours.
More about cancer drugs and oncology treatments at global level
We’re leaders in HIV, focused on ending the global epidemic. We have an industry-leading pipeline, driven by patient insights.
Our infectious diseases portfolio, and including HIV, is the broadest in the industry.
Our awareness campaigns
Childhood Meningitis Campaign
Find out about GSK's campaign to raise awareness of meningitis in children and vaccination against this rare disease.
COPD Campaign
Find out about GSK's COPD (Chronic Obstructive Pulmonary Disease) campaign to raise awareness of the symptoms and risks associated with this disease.
Learn more on our innovation at global level with our "Behind the Science" magazine.
